Duract (bromfenac) was on the U.S. market less than a year

Duract (bromfenac) was on the U.S. market less than a year.It was never approved by HPB...but many Canadians crossed the borderto get this effective NSAID.

When the FDA pulled it, the HPB also issued a warning.

This NSAID worked well for acute pain, but got pulled becauseof reports of severe hepatic failure in patients who used Duract formore than 10 days or had pre-existing hepatic disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote